Literature DB >> 17156899

Role of respiratory syncytial virus in acute otitis media: implications for vaccine development.

Janak A Patel1, Dang T Nguyen, Krystal Revai, Tasnee Chonmaitree.   

Abstract

We summarize herein the results of various virologic studies of acute otitis media (AOM) conducted at our site over a 10-year period. Among 566 children with AOM, respiratory syncytial virus (RSV) was the most common virus identified in either middle ear fluid or nasal wash; it was found in 16% of all children and 38% of virus-positive children. Seventy-one percent of the children with RSV were 1 year of age or older, which was significantly older than all other viruses combined (P=0.045). RSV infection was associated with the common bacterial pathogens causing AOM. Past efforts to develop vaccines for RSV have emphasized prevention of lower respiratory tract infection in infants, which is a more serious problem but less common than AOM. Our results suggest that RSV vaccines that work only against infection in older children may have value in preventing AOM, the most common pediatric disease.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17156899      PMCID: PMC1828634          DOI: 10.1016/j.vaccine.2006.10.045

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  32 in total

1.  Direct expenditures related to otitis media diagnoses: extrapolations from a pediatric medicaid cohort.

Authors:  J Bondy; S Berman; J Glazner; D Lezotte
Journal:  Pediatrics       Date:  2000-06       Impact factor: 7.124

2.  Epidemiology of documented viral respiratory infections and acute otitis media in a cohort of children followed from two to twenty-four months of age.

Authors:  S Vesa; M Kleemola; S Blomqvist; A Takala; T Kilpi; T Hovi
Journal:  Pediatr Infect Dis J       Date:  2001-06       Impact factor: 2.129

3.  Passive immunization for the prevention of otitis media.

Authors:  J A Englund; W P Glezen
Journal:  Vaccine       Date:  2000-12-08       Impact factor: 3.641

4.  National impact of universal childhood immunization with pneumococcal conjugate vaccine on outpatient medical care visits in the United States.

Authors:  Carlos G Grijalva; Katherine A Poehling; J Pekka Nuorti; Yuwei Zhu; Stacey W Martin; Kathryn M Edwards; Marie R Griffin
Journal:  Pediatrics       Date:  2006-09       Impact factor: 7.124

5.  Evaluation of a live, cold-passaged, temperature-sensitive, respiratory syncytial virus vaccine candidate in infancy.

Authors:  P F Wright; R A Karron; R B Belshe; J Thompson; J E Crowe; T G Boyce; L L Halburnt; G W Reed; S S Whitehead; E L Anderson; A E Wittek; R Casey; M Eichelberger; B Thumar; V B Randolph; S A Udem; R M Chanock; B R Murphy
Journal:  J Infect Dis       Date:  2000-09-22       Impact factor: 5.226

6.  Efficacy of a pneumococcal conjugate vaccine against acute otitis media.

Authors:  J Eskola; T Kilpi; A Palmu; J Jokinen; J Haapakoski; E Herva; A Takala; H Käyhty; P Karma; R Kohberger; G Siber; P H Mäkelä
Journal:  N Engl J Med       Date:  2001-02-08       Impact factor: 91.245

Review 7.  Respiratory syncytial virus vaccines for otitis media.

Authors:  L J Anderson
Journal:  Vaccine       Date:  2000-12-08       Impact factor: 3.641

Review 8.  Importance of respiratory viruses in acute otitis media.

Authors:  Terho Heikkinen; Tasnee Chonmaitree
Journal:  Clin Microbiol Rev       Date:  2003-04       Impact factor: 26.132

9.  Middle ear fluid histamine and leukotriene B4 in acute otitis media: effect of antihistamine or corticosteroid treatment.

Authors:  David P McCormick; Kokab Saeed; Tatsuo Uchida; Constance D Baldwin; Ronald Deskin; Michael A Lett-Brown; Terho Heikkinen; Tasnee Chonmaitree
Journal:  Int J Pediatr Otorhinolaryngol       Date:  2003-03       Impact factor: 1.675

10.  Role of respiratory viruses in children with acute otitis media.

Authors:  Hiroko Monobe; Toshio Ishibashi; Yuka Nomura; Masanobu Shinogami; Jun Yano
Journal:  Int J Pediatr Otorhinolaryngol       Date:  2003-07       Impact factor: 1.675

View more
  20 in total

1.  Differential impact of respiratory syncytial virus and parainfluenza virus on the frequency of acute otitis media is explained by lower adaptive and innate immune responses in otitis-prone children.

Authors:  David Verhoeven; Qingfu Xu; Michael E Pichichero
Journal:  Clin Infect Dis       Date:  2014-04-29       Impact factor: 9.079

2.  Replication of respiratory syncytial virus is inhibited by the host defense molecule viperin.

Authors:  Glen McGillivary; Zachary B Jordan; Mark E Peeples; Lauren O Bakaletz
Journal:  J Innate Immun       Date:  2012-09-25       Impact factor: 7.349

3.  Meteorological factors, air pollutants, and emergency department visits for otitis media: a time series study.

Authors:  Massimo Gestro; Vincenzo Condemi; Luisella Bardi; Claudio Fantino; Umberto Solimene
Journal:  Int J Biometeorol       Date:  2017-05-02       Impact factor: 3.787

4.  Viral-bacterial interactions and risk of acute otitis media complicating upper respiratory tract infection.

Authors:  Melinda M Pettigrew; Janneane F Gent; Richard B Pyles; Aaron L Miller; Johanna Nokso-Koivisto; Tasnee Chonmaitree
Journal:  J Clin Microbiol       Date:  2011-09-07       Impact factor: 5.948

Review 5.  Translating Recent Microbiome Insights in Otitis Media into Probiotic Strategies.

Authors:  Marianne F L van den Broek; Ilke De Boeck; Filip Kiekens; An Boudewyns; Olivier M Vanderveken; Sarah Lebeer
Journal:  Clin Microbiol Rev       Date:  2019-07-03       Impact factor: 26.132

6.  Systemic cytokine response profiles associated with respiratory virus-induced acute otitis media.

Authors:  Janak A Patel; Sangeeta Nair; James Grady; Krystal Revai; Sundar Victor; Allan R Brasier; Tasnee Chonmaitree
Journal:  Pediatr Infect Dis J       Date:  2009-05       Impact factor: 2.129

7.  Recombinant simian varicella viruses expressing respiratory syncytial virus antigens are immunogenic.

Authors:  Toby M Ward; Vicki Traina-Dorge; Kara A Davis; Wayne L Gray
Journal:  J Gen Virol       Date:  2008-03       Impact factor: 3.891

Review 8.  Respiratory viruses other than influenza virus: impact and therapeutic advances.

Authors:  W Garrett Nichols; Angela J Peck Campbell; Michael Boeckh
Journal:  Clin Microbiol Rev       Date:  2008-04       Impact factor: 26.132

Review 9.  Unraveling the genetics of otitis media: from mouse to human and back again.

Authors:  Marie S Rye; Mahmood F Bhutta; Michael T Cheeseman; David Burgner; Jenefer M Blackwell; Steve D M Brown; Sarra E Jamieson
Journal:  Mamm Genome       Date:  2010-11-25       Impact factor: 2.957

10.  Viral upper respiratory tract infection and otitis media complication in young children.

Authors:  Tasnee Chonmaitree; Krystal Revai; James J Grady; Audra Clos; Janak A Patel; Sangeeta Nair; Jiang Fan; Kelly J Henrickson
Journal:  Clin Infect Dis       Date:  2008-03-15       Impact factor: 9.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.